Topical interferon Alpha-2b in refractory limbal vernal keratoconjunctivitis: a case report
Keywords:
Vernal keratoconjunctivitis, Interferon alpha-2b, Steroid resistant vernal keratoconjunctivitisAbstract
Purpose: To report our experience of managing a steroid resistant limbal vernal keratoconjunctivitis (VKC) by topical interferon alpha-2b (IFN- 2b) eye drops. Methods: Case report Results: A 20-year-old man was referred to our cornea clinic with the chief complaints of itching and photophobia in eyes and foreign body sensation, redness, and ptosis in a both eyes. He had a 10-year history of gradually enlarging limbal gelatinous masses on both eyes, which according to the other signs and impression cytology (IC) was diagnosed as a VKC. As the disease in his left eye was more severe and persistent with maximum topical steroid usage, we started the topical IFN- 2b eye drops, that a rapid therapeutic response was observed. After three months of using the topical IFN- 2b all ocular surface inflammation and other symptoms rapidly disappeared and we continued this drug till another 3 months, at 12-months follow-up, there was no recurrence of the limbal papillary hypertrophic lesions and other signs and symptoms of VKC. Conclusion: In a refractory VKC, topical IFN- 2b can be used and enhance remission in such complex cases and can resolve patient’s complains rapidly.
Downloads
References
Sangwan VS, Jain V, Vemuganti GK, Murthy SI. Vernal keratoconjunctivitis with limbal stem cell deficiency. Cornea. 2011 May; 30 (5):491-6.
Kheirkhah A, Zavareh M, Farzbod F, Mahbod M, Behrouz MJ. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis. Eye (Lond) 2011;25:872–880.
Baradaran-Rafii A, Akbari M, Shirzadeh E, Shams M. Single block conjunctival limbal autograft for unilateral total limbal stem cell deficiency. J Ophthalmic Vis Res 2015;10:90-2.
Mackensen F, Max R, Becker MD. Interferon therapy for ocular disease. Curr Opin Ophthalmol. 2006;17:567–573.
Esquenazi S. Treatment of early pterygium recurrence with topical administration of interferon alpha-2b. Can J Ophthalmol. 2005;40: 185–187.
Iosseliani DG, Bosha NS, Sandodze TS, Azarov AV, Semitko SP. The effect of revascularization of the internal Carotid artery on the Microcirculation of the eye. J. Adv. Pharm. Educ. & Res| Apr-Jun. 2020;10(2):209-214
Alattas OA, Hamdi AA, Mudarba FM, Alshehri AM, Al-Yahya MS, Almotairi SA, Saeed RA, Buamer MM, Alsuwailem MS, Alamri IA. Red Eye Diagnosis and Management in Primary Health Care. Arch. Pharm. Pract. 2019 Jul 1;10(3).1-5
Dhyani A, Kumar G. A New Vision To Eye: Novel Ocular Drug Delivery System. Pharmacophore. 2019 Apr 1;10(1):13-20.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937
Ghasemi H, Djalilian A. Topical Calcineurin Inhibitors. J Ophthalmic Vis Res 2019;14:398–399.
Akbari M, Moghadam RS, Elmi R, Nosrati A, Taghiabadi E, Aghdami N. Adjunctive Tacrolimus for Herpetic Stromal Keratitis. J Ophthalmic Vis Res 2019; 14: 400–411.
Shoughy SS. Topical tacrolimus in anterior segment inflammatory disorders. Eye Vis (Lond). 2017;4:7.
Akpek EK, Dart JK, Watson S, Christen W, Dursun D, Yoo S, et al. A randomized trial of topical cyclosporine 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology 2004;111:476–482.
Chatterjee A, Bandyopadhyay S, Bandyopadhyay SK. Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children. J Ophthalmic Vis Res 2019;15–21.
Turan-Vural E, Acar BT, Acar S. The efficacy of topical interferon alpha 2b treatment in refractory vernal keratoconjunctivitis. Ocul Immunol Inflamm. 2012;20:125–129.
Zanjani H, Aminifard MN, Ghafourian A, Pourazizi M, Maleki A, Arish M, etal. Comparative Evaluation of Tacrolimus Versus Interferon Alpha-2b Eye Drops in the Treatment of Vernal Keratoconjunctivitis: A Randomized, Double-Masked Study. Cornea 2017;36:675–678.
Akbari M, Elmi R. Herpes Simplex Virus and Human Papillomavirus Coinfections in Hyperimmunoglobulin E Syndrome Presenting as a Conjunctival Mass Lesion. Case Reports in Medicine 2017: Article ID 1650841
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
